A detailed history of Old Point Trust & Financial Services N A transactions in Amgen Inc stock. As of the latest transaction made, Old Point Trust & Financial Services N A holds 24,859 shares of AMGN stock, worth $6.85 Million. This represents 2.95% of its overall portfolio holdings.

Number of Shares
24,859
Previous 25,634 3.02%
Holding current value
$6.85 Million
Previous $8.01 Million -0.0%
% of portfolio
2.95%
Previous 3.17%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$309.38 - $337.38 $239,769 - $261,469
-775 Reduced 3.02%
24,859 $8.01 Million
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $538,637 - $654,585
-2,050 Reduced 7.4%
25,634 $8.01 Million
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $165,355 - $199,604
-615 Reduced 2.17%
27,684 $7.87 Million
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $136,799 - $154,326
-535 Reduced 1.86%
28,299 $8.15 Million
Q3 2023

Nov 09, 2023

SELL
$218.65 - $271.46 $6,559 - $8,143
-30 Reduced 0.1%
28,834 $7.75 Million
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $1,071 - $1,266
5 Added 0.02%
28,864 $6.41 Million
Q1 2023

May 09, 2023

SELL
$225.79 - $275.2 $59,834 - $72,928
-265 Reduced 0.91%
28,859 $6.98 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $106,957 - $135,901
-467 Reduced 1.58%
29,124 $7.65 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $159,366 - $179,736
710 Added 2.46%
29,591 $6.67 Million
Q2 2022

Jul 29, 2022

SELL
$230.71 - $256.74 $312,381 - $347,625
-1,354 Reduced 4.48%
28,881 $7.03 Million
Q1 2022

Apr 28, 2022

BUY
$219.27 - $242.57 $115,993 - $128,319
529 Added 1.78%
30,235 $7.31 Million
Q4 2021

Feb 02, 2022

BUY
$198.88 - $227.6 $105,406 - $120,628
530 Added 1.82%
29,706 $6.68 Million
Q3 2021

Nov 10, 2021

SELL
$212.27 - $248.7 $46,911 - $54,962
-221 Reduced 0.75%
29,176 $6.2 Million
Q2 2021

Aug 10, 2021

BUY
$233.58 - $259.14 $57,694 - $64,007
247 Added 0.85%
29,397 $7.17 Million
Q1 2021

May 10, 2021

BUY
$221.91 - $258.6 $241,881 - $281,874
1,090 Added 3.88%
29,150 $7.25 Million
Q4 2020

Jan 25, 2021

BUY
$216.38 - $257.67 $60,586 - $72,147
280 Added 1.01%
28,060 $6.45 Million
Q3 2020

Oct 27, 2020

SELL
$234.65 - $260.95 $428,001 - $475,972
-1,824 Reduced 6.16%
27,780 $7.06 Million
Q2 2020

Jul 10, 2020

BUY
$197.81 - $242.74 $9,692 - $11,894
49 Added 0.17%
29,604 $6.98 Million
Q1 2020

Apr 15, 2020

SELL
$182.24 - $241.7 $32,438 - $43,022
-178 Reduced 0.6%
29,555 $5.99 Million
Q4 2019

Jan 24, 2020

SELL
$189.21 - $243.2 $113,526 - $145,920
-600 Reduced 1.98%
29,733 $7.17 Million
Q3 2019

Oct 28, 2019

BUY
$174.11 - $208.62 $80,090 - $95,965
460 Added 1.54%
30,333 $5.87 Million
Q2 2019

Jul 05, 2019

BUY
$166.7 - $195.41 $75,015 - $87,934
450 Added 1.53%
29,873 $5.51 Million
Q1 2019

Apr 26, 2019

BUY
$180.87 - $203.88 $56,974 - $64,222
315 Added 1.08%
29,423 $5.59 Million
Q4 2018

Jan 28, 2019

BUY
$178.4 - $208.25 $111,678 - $130,364
626 Added 2.2%
29,108 $5.67 Million
Q3 2018

Nov 02, 2018

BUY
$185.29 - $208.89 $513,253 - $578,625
2,770 Added 10.77%
28,482 $5.9 Million
Q3 2018

Oct 26, 2018

SELL
$185.29 - $208.89 $406,711 - $458,513
-2,195 Reduced 7.87%
25,712 $4.38 Million
Q2 2018

Jul 24, 2018

BUY
$166.05 - $186.51 $364,479 - $409,389
2,195 Added 8.54%
27,907 $5.15 Million
Q1 2018

Apr 26, 2018

BUY
$169.43 - $198.0 $177,054 - $206,910
1,045 Added 4.24%
25,712 $4.38 Million
Q4 2017

Jan 26, 2018

BUY
$168.79 - $188.59 $25,149 - $28,099
149 Added 0.61%
24,667 $4.29 Million
Q3 2017

Oct 24, 2017

BUY
$167.29 - $191.0 $4.1 Million - $4.68 Million
24,518
24,518 $4.57 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $147B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Old Point Trust & Financial Services N A Portfolio

Follow Old Point Trust & Financial Services N A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Point Trust & Financial Services N A, based on Form 13F filings with the SEC.

News

Stay updated on Old Point Trust & Financial Services N A with notifications on news.